A Cost-Effectiveness Analysis of Emicizumab Tre...

By HEOR Staff Writer

April 17, 2024

Introduction: The Future of Haemophilia A Treatment When it comes to rare blood diseases, the introduction of Emicizumab, a bispecific monoclonal antibody, has been a significant milestone in the
Clinical Trials in Saudi Arabia: An Insight from PDC-CRO
A Global Perspective on Orphan Medicines and Rare Diseases
CHMP’s February 2024 Meeting: New Drug Recommendations
Sotatercept for Pulmonary Arterial Hypertension Patients
Groundbreaking Medical Innovations in 2023: FDA approvals
Pharmaceutical Pricing and Reimbursement in Latin America
The Cost-Effectiveness of Efgartigimod Alfa (Vyvgart) in the Treatment of Mya...
Spinal Muscular Atrophy: A Comprehensive Review of Newborn Screening, Treatme...
Enhancing Access: Cross-Sector Collaboration in Healthcare
High-Cost Medicines in Thailand: A Global Perspective and Policy Recommendations